Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's disease

Recent news which mentions Alzheimer's disease

< Previous 1 2 3 4 Next >
Roche's Alzheimer's Candidate Secures FDA Breakthrough Designation
Tickers RHHBF RHHBY RHHVF
Tags Market News Movers RHHBF
From Benzinga
A Harvard nutritional psychiatrist shares the 5 foods she eats to sharpen brain health, memory and focus
Tags Mental health Health Science
From CNBC.com News
Cassava Sciences Starts Late-Stage Simufilam Study In Alzheimer's Patients
Tickers SAVA
Tags Market News Movers Briefs
From Benzinga
See Why Alzamend Neuro Stock Is Rallying On Thursday
Tickers ALZN
Tags Briefs ALZN Preclinical Phase
From Benzinga
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Health Care News Alzheimer's disease
From Benzinga
Aduhelm's 'Blockbuster Potential' Is Underappreciated, Says Biogen Analyst
Tickers BIIB
Tags Market News Analyst Color Health Care
From Benzinga
B. Riley Says Alzheimer's Data From This Firm Has Renewed 'Investor Confidence'
Tickers SAVA
Tags Health Care SAVA Trading Ideas
From Benzinga
Cassava Sciences' Simufilam Data Shows Improved Cognition In Alzheimer's Disease
Tickers SAVA
Tags Health Care SAVA News
From Benzinga
Cassava CEO Goes Offensive Over Data Allegations
Tickers SAVA
Tags Movers Market News Briefs
From Benzinga
Congress Asks For Approval Documents Of Biogen's Alzheimer's Drug: Report
Tickers BIIB
Tags Government FDA Biotech
From Benzinga
What Leerink, Wainwright Have To Say For This Alzheimer's Focused Firm
Tickers ACIU
Tags Long Ideas ACIU Market News
From Benzinga
See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate
Tickers ACIU RHHBF RHHBY RHHVF
Tags RHHBY Phase 2 Trial Biotech
From Benzinga
Amid Medicare Uncertainty, Biogen Offers Its Alzheimer's Drug For Free
Tickers BIIB ESALF ESALY
Tags BIIB Benzinga General
From Benzinga
Cassava Sciences Shares Sink With Alzheimer's Drug Mired In Controversy
Tickers SAVA
Tags FDA Biotech General
From Benzinga
Responses to Questions and Comments: August 2021
Tags INmune Bio (INMB) Cancer coronavirus
From Stock Gumshoe
Biogen's New Alzheimer's Drug Turned Away By Veterans Affairs
Tickers BIIB ESALF ESALY
Tags Biotech Government ESALF
From Benzinga
AbbVie, Mission Therapeutics Pick Alzheimer's & Parkinson's Targets In Neurodegenerative Disease Collaboration
Tickers ABBV
Tags Health Care Benzinga Contracts
From Benzinga
Hoth Therapeutics Starts Preclinical Study For Its Alzheimer's Candidate
Tickers HOTH
Tags HOTH Health Care Benzinga
From Benzinga
I-Mab To Start Testing Alzheimer's Candidate In Human Trials
Tickers IMAB
Tags IMAB Briefs Market News
From Benzinga
Lilly's Donanemab Lowers Alzheimer's-Associated Biomarkers In Patients With Early Disease
Tickers LLY
Tags Benzinga LLY Health Care
From Benzinga
Annovis Bio Shares Cut In Half Following Alzheimer's Data Presentation
Tickers ANVS BIIB
Tags Movers Market News Small Cap
From Benzinga
Anavex Life's Stock Declines Despite Data Shows Alzheimer's Candidate Prevent Abeta-Induced Cognitive Decline In Animal Study
Tickers AVXL
Tags Alzheimer's disease Trading Ideas News
From Benzinga
After Aduhelm Win, Biogen Touts Encouraging Data From Second Alzheimer's Candidate
Tickers BIIB IONS
Tags Aduhelm Biotech General
From Benzinga
Analysis Shows Biogen-Eisai's Aduhelm Slows Cognitive, Functional Decline In Early Alzheimer's Patients
Tickers BIIB ESALF ESALY
Tags Market News ESALY Briefs
From Benzinga
Synaptogenix Stock Drops After Unveiling Analyses Of Alzheimer's Candidate
Tickers ABBV SNPX
Tags News Trading Ideas Alzheimer's disease
From Benzinga
Alzamend Neuro Stock Shoots Higher As Alzheimer's Candidate Shows Encouraging Safety Profile In Animal Models
Tickers ALZN
Tags Health Care News Trading Ideas
From Benzinga
Roche Puts Alzheimer's Candidate, Gantenerumab In Spotlight; In Dialogue with FDA: Reuters
Tickers RHHBF RHHBY RHHVF
Tags Biotech FDA RHHBY
From Benzinga
Annovis Bio's Alzheimer's Candidate To Proceed Into Final Cohort Of Mid-Stage Study, Data Expected In 2022
Tickers ANVS
Tags Biotech Phase 2 Trial Market News
From Benzinga
Alzheimer’s in 2021: Plus ça Change, Plus C’est le Même Chose
Tags Biogen Idec (BIIB) Alzheimer's Disease Doc Gumshoe
From Stock Gumshoe
INmune Bio Issues Equity Raise Of $40M At 18% Discount To Fund Alzheimer's Candidate Development
Tickers INMB
Tags Biotech General Benzinga
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.